3B BlackBio Dx Limited (formerly Kilpest India Limited) has made a regulatory disclosure regarding the sale of 250 equity shares by its promoter, Mahesh Kumar Upadhyay. The transaction took place on March 21, 2025, and was conducted via the open market.

Details of the Transaction

According to the filing, the disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The details of the transaction are summarized as follows:

• Name of the Promoter/Seller: Mahesh Kumar Upadhyay

• Nature of Transaction: Sale of equity shares

• Number of Shares Sold: 250

• Date of Transaction: March 21, 2025

• Mode of Sale: Open Market

• Scrip Code: 532067 (BSE)

Promoter's Holding Before and After Transaction

The promoter’s shareholding position before and after the sale of 250 shares is detailed below:

• Before Sale:

  • Shares Carrying Voting Rights: 24,500

  • Percentage of Total Voting Capital: 0.29%

  • Percentage of Diluted Voting Capital: 0.29%

• After Sale:

  • Shares Carrying Voting Rights: 24,250

  • Percentage of Total Voting Capital: 0.28%

  • Percentage of Diluted Voting Capital: 0.28%

Equity Share Capital of the Company

The equity share capital of 3B BlackBio Dx Limited remains unchanged after the sale:

• Total Equity Share Capital Before and After Sale:
  ₹8,58,26,700, consisting of 85,82,670 equity shares of ₹10 each.

Mode of Sale and Compliance

The sale of the shares was carried out through the open market, ensuring compliance with regulatory norms. As required by SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, the promoter submitted the disclosure on March 22, 2025, to both BSE Limited and the company’s registered office.

Filing of Disclosure

The disclosure was submitted to:

• BSE Limited
  Department of Corporate Relations
  P.J. Towers, Dalal Street, Fort, Mumbai - 400 001

• Company Secretary, 3B BlackBio Dx Limited
  7-C, Industrial Area, Govindpura, Bhopal - 462023, Madhya Pradesh

Regulatory Compliance and Disclosure

The filing is in compliance with Regulation 29(2) of SEBI (SAST) Regulations, 2011, which mandates that promoters disclose transactions involving the acquisition or sale of shares that change their ownership by more than 2% or result in a change in control.

About 3B BlackBio Dx Limited

3B BlackBio Dx Limited is a leading biotechnology company, formerly known as Kilpest India Limited. It operates from its Bhopal-based facility and specializes in molecular diagnostics, offering high-quality diagnostic solutions to the healthcare sector.

The company continues to maintain its compliance with stock exchange regulations, ensuring transparency in promoter transactions and protecting shareholder interests.

Important Note

This disclosure has been made to ensure that the transaction is recorded as per SEBI’s regulatory requirements. Since the promoter’s shareholding remains below 2%, there is no material change in the control or management of the company.

The Upcoming IPOs in this week and coming weeks are Arisinfra Solutions Limited, Desco Infratech Limited, ATC Energies System Limited, Shri Ahimsa Naturals Limited,Identixweb Limited.

The Current active IPO are Rapid Fleet Management Services, Active Infrastructures Limited,Grand Continental Hotels.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.